Description:

E2906 Donor/Transplant Form NCT01041703 Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=842DEB36-F390-AD41-E040-BB89AD4373C4

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=842DEB36-F390-AD41-E040-BB89AD4373C4
Keywords:
  1. 9/19/12 9/19/12 -
  2. 1/8/15 1/8/15 - Martin Dugas
  3. 6/8/15 6/8/15 -
Uploaded on:

June 8, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

E2906 Donor/Transplant Form NCT01041703

INSTRUCTIONS: Complete this form after the allogeneic transplant (30 days post transplant or at the end of hospitalization). Submit original to the ECOG Coordinating Center; keep a copy for your files

ECOG clinical trial administrative data
On Treatment
On Treatment Reporting Period
Data amendment
Vital Status
Patient's Vital Status
Kg
Primary Cause of Death (if applicable)
Donor Information
Donor's Relationship to recipient
Allogeneic Transplant
Did the patient receive protocol transplant?
Reason transplant was not done (If no,)
Comments

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial